Clinical Trial Update: A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and preliminary efficacy of combining rucaparib with radiation in triple-negative breast cancer patients with incomplete r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Rucaparib (rucaparib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2025-12-08